SGRL logo

Shree Ganesh Remedies Limited

SGRL·BSE·
₹691.00▲ +3.70 (+0.54%)
Market Cap887.86 Cr
PE Ratio49.96
Volume119
Day High - Low698.45 - 679.50
52W High-Low749.85 - 477.05

Shree Ganesh Remedies Limited (SGRL): company summary

The company's annual revenue grew 0.6% to ₹109 crore, but net profit fell 23.0% to ₹18 crore.

Shree Ganesh Remedies Limited (SGRL) is a micro-cap Healthcare company valued at ₹888 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move
Shree Ganesh Remedies Limited last traded at ₹691, modestly up 0.54% on the day.
Recent developments
On 2026-06-30, the company reported a sharp decline in both revenue and net profit for the latest quarter compared to the same period a year earlier, raising concerns about its recent operational performance.
Financial performance
The company's annual revenue grew 0.6% to ₹109 crore, but net profit fell 23.0% to ₹18 crore. The latest quarter saw revenue drop 41.8% to ₹14 crore and net profit fall 67.5% to ₹1 crore, indicating a significant slowdown in recent performance.
Valuation multiples
The stock trades at 50.0 times earnings, a premium to the Healthcare median of 32.0, 5.47 times book value.
Things to watch
The company's net profit margin narrowed 5.0 percentage points to 16.3%, and its latest quarter net profit dropped 67.5% from the year-ago period. The stock is 7.7% below its 52-week high, and domestic institutional holding increased by 0.52 points in the quarter.
Where it stands
Shree Ganesh Remedies Limited ended the latest quarter with revenue of ₹14 crore and net profit of ₹1 crore, both down significantly from the year-ago period. The company's net profit margin and recent quarterly performance highlight challenges in maintaining profitability.

Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score
5.8/10
Fair
Fair Value
Sign in to see
ROE
10.90%
Average
P/E
49.96x
Expensive
Debt / Equity
0.19
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

Day₹679.50
₹698.45
52W₹477.05
₹749.85
DocStoX take

Supported by risk (8.6) and momentum (7.5), but held back by valuation (0.0). Risk looks strong at 8.6, but that is offset by valuation at 0.0. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
5.8
/10
Fair
Quality
Solid
ROE 10.9%
Valuation
Expensive
P/E 50.0×
Growth
Steady
Revenue +17.4% 5Y CAGR
Risk
Low risk
D/E 0.19
Momentum
Strong
78% of 52-week range

At a glance

Market Cap
₹888 Cr
52W High / Low
₹750 / ₹477
Dividend Yield
—
Promoter Holding
72.84%
EPS (TTM)
₹13.83
Book Value
₹126.95

Key highlights

  • Low leverage — D/E 0.19
  • Profitable in all of the last 5 years
  • Revenue compounding 17% a year
  • Valuation is weak (0.0/10)
  • Small ₹888 cr company — thinner liquidity
4 Positives2 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Shree Ganesh Remedies Limited peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.